BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25854399)

  • 1. Factors affecting prognosis in metastatic colorectal cancer patients.
    Eker B; Ozaslan E; Karaca H; Berk V; Bozkurt O; Inanc M; Duran AO; Ozkan M
    Asian Pac J Cancer Prev; 2015; 16(7):3015-21. PubMed ID: 25854399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
    Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S
    Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens.
    Massacesi C; Pistilli B; Valeri M; Lippe P; Rocchi MB; Cellerino R; Piga A
    Am J Clin Oncol; 2002 Apr; 25(2):140-8. PubMed ID: 11943891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial.
    Hegewisch-Becker S; Nöpel-Dünnebacke S; Hinke A; Graeven U; Reinacher-Schick A; Hertel J; Lerchenmüller CA; Killing B; Depenbusch R; Al-Batran SE; Lange T; Dietrich G; Tannapfel A; Arnold D
    Eur J Cancer; 2018 Sep; 101():105-113. PubMed ID: 30036739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forty-Two Years' Experience with Pulmonary Resections of Metastases from Colorectal Cancer.
    Dudek W; Schreiner W; Hohenberger W; Klein P; Sirbu H
    Thorac Cardiovasc Surg; 2017 Oct; 65(7):560-566. PubMed ID: 26962969
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
    Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
    Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.
    Kilic L; Yildiz I; Sen FK; Erdem MG; Serilmez M; Keskin S; Ciftci R; Karabulut S; Ordu C; Duranyildiz D; Tas F
    Cancer Biomark; 2015; 15(4):405-11. PubMed ID: 25792472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma.
    Vukobrat-Bijedic Z; Husic-Selimovic A; Sofic A; Bijedic N; Bjelogrlic I; Gogov B; Mehmedovic A
    Med Arch; 2013 Dec; 67(6):397-401. PubMed ID: 25568506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer.
    Neki K; Eto K; Kosuge M; Ohkuma M; Ito D; Takeda Y; Yatabe S; Sugano H; Yanaga K
    Anticancer Res; 2019 Oct; 39(10):5721-5724. PubMed ID: 31570473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal Carcinoma.
    Osoegawa A; Kometani T; Fukuyama S; Hirai F; Seto T; Sugio K; Ichinose Y
    Ann Thorac Cardiovasc Surg; 2016; 22(1):6-11. PubMed ID: 26289631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
    Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
    Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients.
    Sisik A; Kaya M; Bas G; Basak F; Alimoglu O
    Asian Pac J Cancer Prev; 2013; 14(7):4289-94. PubMed ID: 23991991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study.
    Chen KH; Shao YY; Chen HM; Lin YL; Lin ZZ; Lai MS; Cheng AL; Yeh KH
    BMC Cancer; 2016 May; 16():327. PubMed ID: 27221731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival.
    Lee SJ; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS; Kim ST
    Clin Colorectal Cancer; 2018 Sep; 17(3):165-169. PubMed ID: 29576428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.